To determine the role of IL-35 in immunosuppression, we treated CFSE-labeled CD4+CD25− T cells obtained from HD with a series of concentrations of rhIL-35 ranging from 0 ng/ml to 200 ng/ml for 5 days and then detected cell proliferation using FACS. The gene discussed is CD4; the disease is Huntington disease.